Augmentation of wound healing using monochromatic infrared energy. Exploration of a new technology for wound management.
The results presented in this paper document healing of different types of extremity wounds with 890 nanometer (nm) monochromatic infrared energy. Recalcitrant dermal lesions, including venous ulcers, diabetic ulcers, and a wound related to scleroderma, were treated with a Food and Drug Administration-cleared infrared device. The infrared protocol was instituted after conventional management protocols were shown to be ineffective. The rate and quality of healing of these previously refractory wounds, following use of monochromatic infrared energy, may be related to local increases in nitric oxide concentration. Increases in nitric oxide previously have been demonstrated to correlate with vasodilatory and anabolic responses. Further research is needed to confirm the results found in these patients.
D002985:Clinical Protocols; D005260:Female; D006801:Humans; D007259:Infrared Rays / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009569:Nitric Oxide / Q000378:metabolism; D016896:Treatment Outcome; D014945:Wound Healing / Q000528:radiation effects*; D014947:Wounds and Injuries / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*